SC 13D Filing

Company

ADC Therapeutics SA

Filed

May 29, 2020

Accession Number

0001011438-20-000140

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →